
Release date: 2026-04-01 16:28:41 Article From: Lucius Laos Recommended: 232
While effectively inhibiting tumor growth, erlotinib may also cause a range of side effects. These adverse reactions vary from person to person. Most patients may experience mild to moderate skin reactions, gastrointestinal discomfort, and other symptoms; some patients may also develop more severe symptoms.
Burning, tingling, numbness, or pain in the hands, arms, feet, or legs; cough or hoarseness; severe diarrhea; difficulty breathing or shortness of breath; fever or chills; lower back or side pain; painful or difficult urination; severe rash; tingling sensation; stabbing chest pain; tightness in the chest.
Blood in or black, tarry stools; blurred vision; chest pain or discomfort; constipation; convulsions (seizures); eye irritation or redness; inability to speak; pain or discomfort in the arms, jaw, back, or neck; severe abdominal pain; slurred speech; sudden severe chest pain; sudden severe headache; sudden severe weakness in the arm or leg on one side of the body; sweating; changes in vision; vomiting blood or coffee-ground-like material.
Gastrointestinal system: Acid reflux or sour stomach, belching, bloating or a feeling of fullness, mild diarrhea, flatulence, heartburn, indigestion, stomach upset, nausea or abdominal pain, passing gas.
Skin, hair and mucosal system: Skin blemishes, dry skin, hair loss, itching skin, papules, mild rash, thinning hair, swelling or inflammation of the mouth.
Ocular system: Burning, dryness or itching of the eyes; dry eyes; excessive tearing; redness, pain or swelling of the eyes/eyelids/conjunctiva.
Musculoskeletal system: Bone pain, difficulty moving, joint pain, joint swelling.
Nervous system: Dizziness, tremors, difficulty falling asleep or insomnia, impaired concentration.
Psychiatric system: Fear, depression or emptiness, irritability, loss of interest or pleasure, nervousness.
General symptoms: Abnormal cold intolerance, fatigue, swelling, weight loss.
Loosening of the fingernails or toenails; redness or pain around the nails.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643